Mount Sinai School of Medicine; Dermatology

New York, New York 10029

0 studies enrolling now · 1 studies all time

What they study most

Basal Cell Carcinoma

Studies at this site

• A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) in Patients With Advanced Basal Cell Carcinoma — Completed